相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Daniela Unterleuthner et al.
ANGIOGENESIS (2020)
Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway
Jinghua Cao et al.
ANGIOGENESIS (2020)
Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor-kappa B/MDR1 pathway in colorectal cancer
Zhan Yueping et al.
CANCER SCIENCE (2020)
Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models
Somshuvra Bhattacharya et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells
Xia Liu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells
Lijun Liang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Vessel co-option in cancer
Elizabeth A. Kuczynski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Cancer-associated fibroblasts in gastrointestinal cancer
Hiroki Kobayashi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer
Jian-Feng Liu et al.
MOLECULAR CARCINOGENESIS (2018)
Combinations of Bevacizumab and Erlotinib Show Activity in Colorectal Cancer Independent of RAS Status
Paul Mesange et al.
CLINICAL CANCER RESEARCH (2018)
The role of tumor angiogenesis as a therapeutic target in colorectal cancer
Francesca Battaglin et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
BF211, a derivative of bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6/JAK2/STAT3 pathway
Xiao-yu Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin
Yong Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model
Denver D. Britto et al.
DISEASE MODELS & MECHANISMS (2018)
Expression of STAT3 in Prostate Cancer Metastases
Nicholas Don-Doncow et al.
EUROPEAN UROLOGY (2017)
Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells
Jian Sun et al.
ONCOLOGY REPORTS (2017)
MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling
Yan-e Du et al.
THERANOSTICS (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
Role of the Microenvironment in Liver Metastasis: From Pre- to Prometastatic Niches
Pnina Brodt
CLINICAL CANCER RESEARCH (2016)
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling
Haiyong Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer
Yuan-Ming Pan et al.
MOLECULAR CANCER (2016)
SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin
Lei Dai et al.
NATURE COMMUNICATIONS (2016)
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial
Christophe Tournigand et al.
LANCET ONCOLOGY (2015)
Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo
Nadine Jetten et al.
ANGIOGENESIS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Bufalin induces G0/G1 phase arrest through inhibiting the levels of cyclin D, cyclin E, CDK2 and CDK4, and triggers apoptosis via mitochondrial signaling pathway in T24 human bladder cancer cells
Wen-Wen Huang et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice
Maciej Kujawski et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: From the biology to the clinic
Girolamo Ranieri et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis
DY Wei et al.
ONCOGENE (2003)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
分享论文
